<DOC>
	<DOCNO>NCT01322308</DOCNO>
	<brief_summary>The present study aim investigate effect pioglitazone ( 30 mg/day ) endothelial function premenopausal woman SLE ( systemic lupus erythematosus ) . Patients hypertension , endocrine , hepatic renal disease include , pregnant /breast feed woman . This randomized , double blind , placebo control study .</brief_summary>
	<brief_title>Effect Pioglitazone Endothelial Function Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus</brief_title>
	<detailed_description>SLE ( systemic lupus erythematosus ) characterize accelerated atherosclerosis . The risk suffer acute myocardial infarction among premenopausal woman SLE 50 time higher control woman age . Insulin resistance hyperinsulinemia frequent SLE . Lipid metabolism SLE , insulin resistant state , characterize high triglyceride , low HDL-cholesterol , normal LDL cholesterol ( slightly increase ) increase LDL 's susceptibility oxidation . All alteration produce endothelial dysfunction present SLE patient . Pioglitazone PPAR ( peroxisome proliferator activate receptor ) gamma agonist potentially improve insulin resistance , positive effect lipid profile ( lower triglyceride , discrete increase HDL-C ) improve endothelial function . Patients randomize receive either placebo pioglitazone 30 mg/day period 12 week . Endothelial function assess Positron Emission Tomography ( PET ) .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Eligible participant premenopausal woman SLE Older 18 year Attending outpatient Rheumatology Clinic three Mexico City community tertiary care hospital menopause diabetes thyroid dysfunction neurological hepatic renal liver disease personal history high blood pressure CHD ( coronary heart disease ) cerebrovascular event chronic acute infection malignancy history chronic drug alcohol abuse smoke pregnancy breastfeed intake hormone lipidregulating drug</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>lupus</keyword>
	<keyword>HDL particle</keyword>
	<keyword>endothelial function</keyword>
	<keyword>pioglitazone</keyword>
</DOC>